Literature DB >> 28381875

Masked uncontrolled hypertension in patients on maintenance hemodialysis.

Wenjin Liu1, Liang Wang2, Zhuxing Sun2, Xiurong Li3, Jianmei Zhou4, Chaoqing Gao4, Hong Chu5, Wei Fan5, Youwei Bai6, Junwei Yang1.   

Abstract

Masked uncontrolled hypertension (MUCH) has been proven to be associated with increased cardiovascular risk in the general population. We performed the current analysis to determine its prevalence in dialysis patients and its association with pulse wave velocity (PWV). From 368 participants of another cohort study, we selected 145 subjects with controlled predialysis blood pressure (BP). All subjects underwent ambulatory BP monitoring and PWV measurement. MUCH was defined as controlled predialysis BP with daytime BP⩾135/85 mm Hg (definition-1); total ambulatory BP⩾130/80 mm Hg (definition-2); and either daytime BP⩾135/85 mm Hg or nighttime BP⩾120/70 mm Hg (definition-3). The prevalence of MUCH was 43.4% (definition-1), 55.9% (definition-2) and 74.5% (definition-3). Multivariable logistic regression analysis showed that the use of antihypertensive medication was the most consistent predictor of MUCH within all 3 definitions (all odds ratio (OR)⩾4.28, P<0.001). Predialysis systolic BP (both OR>1, P⩽0.04), predialysis diastolic BP (both OR>1, P⩽0.001) and hemoglobin (both OR<1, P=0.02) were all significantly associated with MUCH in two models. Interdialytic weight gain (OR=0.52, P=0.02) was associated with MUCH under definition-2, and BMI (OR=0.86, P=0.03) was associated with MUCH under definition-3. Patients with MUCH had significantly elevated PWV compared with their counterparts according to all three definitions with or without adjusting for covariates (all P⩽0.03). In conclusion, MUCH affects a large proportion of dialysis patients with controlled predialysis BP and is associated with increased PWV. Patients on antihypertensive medications and with higher predialysis BP are more likely to have MUCH.

Entities:  

Mesh:

Year:  2017        PMID: 28381875     DOI: 10.1038/hr.2017.48

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  33 in total

1.  K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.

Authors: 
Journal:  Am J Kidney Dis       Date:  2005-04       Impact factor: 8.860

2.  Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.

Authors:  Paul E Drawz; Arnold B Alper; Amanda H Anderson; Carolyn S Brecklin; Jeanne Charleston; Jing Chen; Rajat Deo; Michael J Fischer; Jiang He; Chi-Yuan Hsu; Yonghong Huan; Martin G Keane; John W Kusek; Gail K Makos; Edgar R Miller; Elsayed Z Soliman; Susan P Steigerwalt; Jonathan J Taliercio; Raymond R Townsend; Matthew R Weir; Jackson T Wright; Dawei Xie; Mahboob Rahman
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-18       Impact factor: 8.237

Review 3.  Prevalence of white-coat and masked hypertension in national and international registries.

Authors:  Manuel Gorostidi; Ernest Vinyoles; José R Banegas; Alejandro de la Sierra
Journal:  Hypertens Res       Date:  2014-10-16       Impact factor: 3.872

4.  Toward a definition of masked hypertension and white-coat hypertension among hemodialysis patients.

Authors:  Rajiv Agarwal; Arjun D Sinha; Robert P Light
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

5.  Identifying masked uncontrolled hypertension in the community pharmacy setting.

Authors:  Daniel Sabater-Hernández; Jose Sendra-Lillo; Jose J Jiménez-Monleón; Shalom I Benrimoj; Desire Durks; Fernando Martínez-Martínez; Alejandro de la Sierra
Journal:  Blood Press Monit       Date:  2015-06       Impact factor: 1.444

6.  Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients.

Authors:  Giovanni Tripepi; Riccardo Maria Fagugli; Pietro Dattolo; Giovanna Parlongo; Francesca Mallamaci; Umberto Buoncristiani; Carmine Zoccali
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

7.  Blood pressure and mortality among hemodialysis patients.

Authors:  Rajiv Agarwal
Journal:  Hypertension       Date:  2010-01-18       Impact factor: 10.190

8.  Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study.

Authors:  Kevin C Abbott; Christopher W Glanton; Fernando C Trespalacios; David K Oliver; Maria I Ortiz; Lawrence Y Agodoa; David F Cruess; Paul L Kimmel
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

9.  Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH).

Authors:  Nabil Naser; Alen Dzubur; Azra Durak; Mehmed Kulic; Nura Naser
Journal:  Med Arch       Date:  2016-07-27

10.  High prevalence of masked uncontrolled hypertension in people with treated hypertension.

Authors:  José R Banegas; Luis M Ruilope; Alejandro de la Sierra; Juan J de la Cruz; Manuel Gorostidi; Julián Segura; Nieves Martell; Juan García-Puig; John Deanfield; Bryan Williams
Journal:  Eur Heart J       Date:  2014-02-03       Impact factor: 29.983

View more
  2 in total

1.  Is Ambulatory Blood Pressure Monitoring Required for Elderly Hemodialysis Patients during the Interdialytic Period? - Experience of a Tertiary Care Center in South India.

Authors:  E Indhumathi; Srivatsa Angraje; Biswajith Mishra; Jayakumar Macha
Journal:  Indian J Nephrol       Date:  2021-11-09

2.  Autonomic dysregulation and phenobarbital in patients with masked primary hypertension.

Authors:  Mustapha El Bakkali; Souad Aboudrar; Taoufiq Dakka; Halima Benjelloun
Journal:  Heliyon       Date:  2020-01-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.